Zomedica Corp. (ZOMDF): Cash & Equivalents
$9.02M
As of 2025-12-31
$7.19M
As of 2026-06-30
-31.0%
3-year compound annual growth
-32.0%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.02M | +28.4% | 2026-03-16, Balance as of period end |
| 2024-12-31 | $7.02M | -45.8% | 2026-03-16, Balance as of period end |
| 2023-12-31 | $12.95M | -52.7% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $27.40M | -85.9% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $194.95M | +214.5% | 2023-03-15, Balance as of period end |
| 2020-12-31 | $61.99M | n/m | 2022-03-01, Balance as of period end |
| 2019-12-31 | $510.6K | -73.7% | 2021-02-26, Balance as of period end |
| 2018-12-31 | $1.94M | -43.7% | 2020-02-26, Balance as of period end |
| 2017-12-31 | $3.45M | +6.9% | 2019-03-14, Balance as of period end |
| 2016-12-31 | $3.23M | n/a | 2018-02-28, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $9.02M | +28.4% |
| Verastem, Inc. (VSTM) | 2025-12-31 | $204.99M | +130.8% |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $80.88M | +45.8% |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | $23.02M | +863.4% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $30.15M | -34.9% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $796.8K | -45.9% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $1.77M | -17.7% |
| Cue Biopharma, Inc. (CUE) | 2025-12-31 | $27.14M | +20.8% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $9.82M | 0.0% |
Compare ZOMDF, VSTM, FHTX, BHST side by side · Screen every company in Pharmaceutical Preparations ↗